Do ARKG and FBT hold the same stocks?

By their latest filings, 9% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.

Which is more different from the S&P 500, ARKG or FBT?

ARKG has 5% of its weight in S&P 500 names and FBT has 25%, so FBT differs more from the index.

Which is cheaper, ARKG or FBT?

ARKG charges 0.75% a year and FBT charges 0.55%, so FBT is cheaper. Fees come from each fund's prospectus.

Data as of Nov 4, 2026.

Thematic ETFs

ARKG vs FBT: Holdings Overlap & Returns

Share on X Download as PDF

Over the year to Nov 4, 2026, ARKG returned +68.4% to FBT's +47.0%; 9% of their weight is in the same names.

askIQ about this page

askIQ about ARKG and FBT

Net assets: $2.1bn on Nov 2, 2026 for ARK Genomic Revolution ETF, and $3.1bn on Nov 3, 2026 for First Trust NYSE Arca Biotechnology Index Fund.

ARKG on its own →FBT on its own →

At a glance

4.6%

ARKG in the S&P 500

24.8%

FBT in the S&P 500

+68.4%

ARKG total return, 1 year

+47.0%

FBT total return, 1 year

ARKG · 1 year to Nov 4, 2026 95% of its weight is outside the S&P 500

5% of ARKG's weight is in S&P 500 companies and 95% is outside the index. Holdings as of Nov 2, 2026.

FBT · 1 year to Nov 4, 2026 75% of its weight is outside the S&P 500

25% of FBT's weight is in S&P 500 companies and 75% is outside the index. Holdings as of Nov 3, 2026.

Pair scorecard

FBT costs 0.20 points a year less; their one-year returns differ by 21.4 points; FBT is 1.5 times larger.

ARKG vs FBT: Holdings Overlap & Returns
Measure	ARKG	FBT
Return
Measure	ARKG	FBT
Total return, 1 year	+68.4%	+47.0%
Drawdown
Measure	ARKG	FBT
Below its all-time high	55.5%, high on Jan 20, 2021
Benchmark
Measure	ARKG	FBT
What it tracks	Genomics and gene editing	Biotech
Cost and size
Measure	ARKG	FBT
Expense ratio	0.75%	0.55%
Net assets, as of Nov 2, 2026	$2.1bn	$3.1bn
Active share vs the S&P 500	98%	99%
Holdings
Measure	ARKG	FBT
Holdings in common	9%
Top ten holdings, share of the fund	58%	38%

Method

Risk and return

Nov 7, 2014 to Oct 30, 2026 · 625 weekly returns

ARKG FBT

Return

Total return edge FBT (slight) +179.6% +192.9%

Annualized edge FBT (slight) +8.9% +9.4%

Price return edge FBT +161.6% +186.5%

Risk

Volatility edge FBT 39.8% 24.0%

Max drawdown edge FBT −82.9% −38.2%

Risk-adjusted

Sharpe edge FBT 0.36 0.40

Sortino edge FBT (slight) 0.55 0.60

Calmar edge FBT 0.11 0.24

Reading

From Nov 2014 to Oct 2026, FBT returned slightly more: +192.9% to +179.6%. FBT swung less: 24.0% to 39.8%. FBT fell less at its worst: −38.2% to −82.9%.

Full scorecard

9 measures, with how each is measured Open ↓

Risk and return: ARKG vs FBT: Holdings Overlap & Returns
Measure	ARKG	FBT	Edge	How it is measured
Return
Total return	+179.6%	+192.9%	FBT (slight)	Price change plus distributions, reinvested.
Annualized	+8.9%	+9.4%	FBT (slight)	Total return as a yearly rate.
Price return	+161.6%	+186.5%	FBT	Price change alone, distributions left out.
Risk
Volatility	39.8%	24.0%	FBT	Spread of weekly returns, annualized. Lower is steadier.
Downside deviation	26.2%	16.2%	FBT	Like volatility, counting only weeks below the Treasury bill rate.
Max drawdown	−82.9%	−38.2%	FBT	Deepest fall from a high to the low after it.
Risk-adjusted
Sharpe	0.36	0.40	FBT	Return above Treasury bills per unit of volatility.
Sortino	0.55	0.60	FBT (slight)	Return above Treasury bills per unit of downside deviation.
Calmar	0.11	0.24	FBT	Annualized return divided by the max drawdown.

Computed by ETFIQ from Tiingo daily prices and ETFIQ's distribution records, 625 weekly returns. Cash rate: the 13-week Treasury bill.

What they share

By the books each fund has filed, ARKG and FBT hold 9% of their money in the same securities at the same weight. Holdings dated Nov 2, 2026 and Nov 3, 2026.

50%

0 half 100%

half

9% in common

Positions both hold · largest shared weight first ARKG FBT

VERACYTE INC 3.80% 3.57%

NATERA INC 4.67% 3.11%

ILLUMINA INC 4.26% 2.75%

Only in one fund ↓

Only in ARKG

TEMPUS AI INC-CL A 9.85%

10X GENOMICS INC-CLASS A 7.52%

TWIST BIOSCIENCE CORP 7.42%

CRISPR THERAPEUTICS AG 5.48%

GUARDANT HEALTH INC 5.13%

ABSCI CORP 5.08%

ELI LILLY & CO 4.59%

CAREDX INC 4.50%

Only in FBT

Genmab A/S (ADR) 4.81%

Regeneron Pharmaceuticals, Inc. 4.18%

Exelixis, Inc. 3.88%

Halozyme Therapeutics, Inc. 3.74%

Neurocrine Biosciences, Inc. 3.71%

Alkermes Plc 3.61%

Amgen Inc. 3.57%

Gilead Sciences, Inc. 3.56%

Check overlap with more funds →

Window by window

Window by window: ARKG vs FBT: Holdings Overlap & Returns
	Total return
Window	ARKG	FBT
3 months	+20.5%	+12.2%
6 months	+60.0%	+30.5%
1 year	+68.4%	+47.0%
3 years	+90.8%	+100.5%
Since launchNot the same days: ARKG Oct 2014 · FBT Jun 2006	+164.2%	+1,349.5%

Open this comparison in the app →

Side by side

ARKG ARK Genomic Revolution ETF · Holds 35 stocks in genomics and gene editing, 5% of its weight in S&P 500 companies FBT First Trust NYSE Arca Biotechnology Index Fund · Holds 30 stocks in biotech, 25% of its weight in S&P 500 companies

Issuer ARK First Trust

Theme Genomics and gene editing Biotech

In the S&P 500 4.6% 24.8%

Active share vs the S&P 500 98.5% 99.1%

In the Nasdaq-100 0.0% 16.9%

Holdings 35 30

Top ten, share of the fund 58.5% 38.2%

Expense ratio 0.75% 0.55%

Fee for the differing part 0.76% 0.55%

Total return, 1 year +68.4% +47.0%

vs its benchmark not measured not measured

Below its high −55.5% −0.3%

Net assets, ARKG as of Nov 2, 2026 and FBT as of Nov 3, 2026 $2.1bn $3.1bn

As of Nov 4, 2026. Source: ETFIQ.

9% of the two portfolios are the same securities at the same weight.

Client brief:

The two-page PDF for this pair is coming. Save the comparison to follow its changes. Free. It needs an email sign-in, once.

Your saved page · Privacy.

Alert

About each fund

ARKG

By weight, 5% of ARKG's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 58% of the fund across 35 positions, as published by its issuer for Nov 2, 2026. Over the year to Nov 4, 2026 the fund returned +68.4% with distributions reinvested. It sits 55.5% below its all-time high of Jan 20, 2021.

FBT

By weight, 25% of FBT's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 38% of the fund across 30 positions, as published by its issuer for Nov 3, 2026. Over the year to Nov 4, 2026 the fund returned +47.0% with distributions reinvested.

Questions people ask

Do ARKG and FBT hold the same stocks?: By their latest filings, 9% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Which is more different from the S&P 500, ARKG or FBT?: ARKG has 5% of its weight in S&P 500 names and FBT has 25%, so FBT differs more from the index.
Which is cheaper, ARKG or FBT?: ARKG charges 0.75% a year and FBT charges 0.55%, so FBT is cheaper. Fees come from each fund's prospectus.

Other comparisons

ARKG vs IBB ARKG vs BBP ARKG vs PBPH ARKG vs XBI FBT vs IDNA FBT vs GNOM FBT vs GNMX FBT vs PBPH

Where to next

All thematic ETFs ranked by the S&P 500 Difference Score →How the scores are computed →ARKG on its own →FBT on its own →ARKG holdings →FBT dividend history →FBT holdings →Method →Standards and sources →

Sources and dates

ARKG filings on SEC EDGAR ↗

ARKG prospectus with the expense ratio (SEC) ↗

ARK page for ARKG ↗

FBT filings on SEC EDGAR ↗

FBT prospectus with the expense ratio (SEC) ↗

First Trust page for FBT ↗

Links are sources, not endorsements. A comparison is not a recommendation.

How this is computed

Overlap adds up the smaller of the two weights for each security both funds hold.

Every number is an ETFIQ calculation with distributions reinvested.

Cite this pageCitation, APA and Markdown

ETFIQ, ARKG against FBT, data as of Nov 4, 2026. https://etfiq.com/compare/themes/arkg-vs-fbt

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.